Is BMS1 p.Phe1237Leu (c.3711C>A) pathogenic?

BMS1 p.Phe1237Leu (c.3711C>A) is classified Uncertain significance in BMS1 (ClinVar, Single submitter, 1 submitter; last evaluated 2024-05-26). AlphaMissense: likely benign (0.2151); Rare (popmax 0.154%, afr).

How common is BMS1 p.Phe1237Leu (c.3711C>A) in the general population?

BMS1 p.Phe1237Leu (c.3711C>A) is rare (popmax 0.154%, afr) (gnomAD).

What do computational predictors say about BMS1 p.Phe1237Leu (c.3711C>A)?

AlphaMissense predicts likely benign (score 0.2151) — an in-silico prediction, not a clinical call.

BMS1 p.Phe1237Leu

c.3711C>A · rs183287025 · VCV3134626

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.2151 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.154%, afr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.2151	likely benign
REVEL	0.045	moderately benign-leaning
SaProt	LLR -5.31	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.25	GERP -1.5, phastCons 0.82
Regional constraint	o/e 0.75	unconstrained · MANE · 14 kb · p 1.9e-09 · regional, not allelic
Overall
CADD	14.18	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.154% African / African-American · 115/74,844 alleles

Filtering AF 0.131% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.122%

Overall 0.0087% 140/1,609,624 alleles · rare

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.154%	651
Admixed American	0.0269%	3,716
Remaining individualsnot grpmax-eligible	0.0128%	7,798
European (non-Finnish)	8.49e-05%	1,177,876

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: BMS1
Protein: p.Phe1237Leu
Coding: c.3711C>A
MANE Select: NM_014753
dbSNP: rs183287025
Type: single nucleotide variant
Location: chr10:42830958 (GRCh38)
Gene constraint: LOEUF 0.507 · pLI 0.50 (gnomAD)
Structure: AlphaFold pLDDT 72.04 · 3 PDB
Residue 1237: an α-helix; the 'disordered' region

Full BMS1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

BMS1 p.Ala214Val Benign/Likely benign ★★ same type
BMS1 p.Ala500= Benign/Likely benign ★★ same type
BMS1 p.Arg237His Benign ★★ same type
BMS1 p.Arg38Trp Benign/Likely benign ★★ ⚠ same type
BMS1 p.Arg863= Benign ★★ same type
BMS1 p.Asp768Asn Benign ★★ same type
BMS1 p.Glu1278= Likely benign ★★ same type
BMS1 p.Ile942= Benign/Likely benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bms1-p-phe1237leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown